Crossbow Therapeutics is a brand determined to revolutionize the reach of cancer treatment by developing potent and precise therapies. Their goal is to create an arsenal of therapeutics that expand the reach and impact of antibodies used to treat cancer. With a focus on curing cancer, Crossbow Therapeutics aims to broaden the benefits of immunotherapy and improve the lives of people living with cancer.

Their next-generation therapies, known as T-Bolt molecules, embody the precision and power of a crossbow. These therapies strike tumor cells with unparalleled accuracy and potency, similar to how a crossbow shoots bolts at its target. Crossbow Therapeutics identifies, validates, and prioritizes the most promising cancer antigens for their T-Cell Receptor Mimetic (TCRm) discovery efforts.

Their team consists of international, collaborative, and experienced inventors, drug developers, and company builders. They value scientific excellence, passion, integrity, innovation, transparency, respect, and accountability. With a strong leadership team and a focus on innovation, Crossbow Therapeutics is committed to expanding the reach of antibody therapeutics and transforming cancer treatment